Efficacy and safety of nimotuzumab in addition to radiotherapy and temozolomide for cerebral glioblastoma: a phase II multicenter clinical trial.
Du XJ, Li XM, Cai LB, Sun JC, Wang SY, Wang XC, Pang XL, Deng ML, Chen FF, Wang ZQ, Chen FR, Zhang HH, Wang HY, Piedra P, Chen ZP, Lin J, Wu SX.
Du XJ, et al. Among authors: lin j.
J Cancer. 2019 Jun 2;10(14):3214-3223. doi: 10.7150/jca.30123. eCollection 2019.
J Cancer. 2019.
PMID: 31289592
Free PMC article.